The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(4-((N-p-tolylphenylsulfonamido)methyl)-1H-1,2,3-triazol-1-yl)tetrahydrofuran-3,4-diyl diacetate ID: ALA4103273
PubChem CID: 137656439
Max Phase: Preclinical
Molecular Formula: C27H30N4O9S
Molecular Weight: 586.62
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)OC[C@H]1O[C@@H](n2cc(CN(c3ccc(C)cc3)S(=O)(=O)c3ccccc3)nn2)[C@H](OC(C)=O)[C@@H]1OC(C)=O
Standard InChI: InChI=1S/C27H30N4O9S/c1-17-10-12-22(13-11-17)31(41(35,36)23-8-6-5-7-9-23)15-21-14-30(29-28-21)27-26(39-20(4)34)25(38-19(3)33)24(40-27)16-37-18(2)32/h5-14,24-27H,15-16H2,1-4H3/t24-,25-,26-,27-/m1/s1
Standard InChI Key: MHLCDZHRMMBKNK-FPCALVHFSA-N
Molfile:
RDKit 2D
41 44 0 0 0 0 0 0 0 0999 V2000
15.9542 -8.3750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.5458 -9.0916 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
16.3706 -9.0870 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1625 -10.1709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9875 -10.1709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2442 -9.3867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5750 -8.9000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.9099 -9.3867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0292 -9.1328 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4716 -10.8389 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6767 -10.8377 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1252 -9.1321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5124 -9.6844 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7276 -9.4298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1147 -9.9822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5557 -8.6230 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0112 -11.5918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5254 -12.2586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8316 -11.6790 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2921 -10.7536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7763 -11.4216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6286 -10.0003 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.6983 -9.6153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3664 -9.1313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1125 -8.3463 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2876 -8.3453 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1507 -9.3873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7645 -8.8362 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5941 -8.0290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7192 -9.8994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2093 -7.4836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0394 -6.6771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2545 -6.4204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6392 -6.9764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8123 -7.7808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1046 -10.4478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2775 -11.2549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0644 -11.5093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6787 -10.9504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5027 -10.1454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0830 -5.6134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 4 1 0
6 9 1 1
5 10 1 6
4 11 1 6
8 12 1 1
12 13 1 0
13 14 1 0
14 15 1 0
14 16 2 0
11 17 1 0
17 18 1 0
17 19 2 0
10 20 1 0
20 21 1 0
20 22 2 0
9 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 9 1 0
24 27 1 0
27 28 1 0
28 2 1 0
28 29 1 0
2 30 1 0
29 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 29 1 0
30 36 2 0
36 37 1 0
37 38 2 0
38 39 1 0
39 40 2 0
40 30 1 0
33 41 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 586.62Molecular Weight (Monoisotopic): 586.1733AlogP: 2.31#Rotatable Bonds: 10Polar Surface Area: 156.22Molecular Species: NEUTRALHBA: 12HBD: ┄#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 2.59CX LogD: 2.59Aromatic Rings: 3Heavy Atoms: 41QED Weighted: 0.25Np Likeness Score: -0.52
References 1. Alaoui S, Dufies M, Driowya M, Demange L, Bougrin K, Robert G, Auberger P, Pagès G, Benhida R.. (2017) Synthesis and anti-cancer activities of new sulfonamides 4-substituted-triazolyl nucleosides., 27 (9): [PMID:28325600 ] [10.1016/j.bmcl.2017.03.018 ]